Northern Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $76.8M | Buy |
445,382
+6,221
| +1% | +$1.15M | 0.01% | 867 |
|
|
2025
Q4 | $87.6M | Sell |
439,161
-37,303
| -8% | -$6.77M | 0.01% | 797 |
|
|
2025
Q3 | $74.5M | Sell |
476,464
-721
| -0.2% | -$115K | 0.01% | 881 |
|
|
2025
Q2 | $72.4M | Sell |
477,185
-15,285
| -3% | -$2.04M | 0.01% | 870 |
|
|
2025
Q1 | $74.1M | Buy |
492,470
+252
| +0.1% | +$42.3K | 0.01% | 847 |
|
|
2024
Q4 | $90.9M | Buy |
492,218
+58,398
| +13% | +$11.2M | 0.01% | 774 |
|
|
2024
Q3 | $85.4M | Sell |
433,820
-24,077
| -5% | -$5M | 0.01% | 712 |
|
|
2024
Q2 | $94.6M | Sell |
457,897
-1,354
| -0.3% | -$307K | 0.02% | 650 |
|
|
2024
Q1 | $124M | Sell |
459,251
-21,135
| -4% | -$5.05M | 0.02% | 555 |
|
|
2023
Q4 | $114M | Sell |
480,386
-17,081
| -3% | -$3.36M | 0.02% | 579 |
|
|
2023
Q3 | $97.5M | Buy |
497,467
+24,249
| +5% | +$4.98M | 0.02% | 603 |
|
|
2023
Q2 | $99.5M | Sell |
473,218
-17,809
| -4% | -$3.54M | 0.02% | 603 |
|
|
2023
Q1 | $99.1M | Sell |
491,027
-5,272
| -1% | -$1.19M | 0.02% | 605 |
|
|
2022
Q4 | $108M | Buy |
496,299
+1,724
| +0.3% | +$376K | 0.02% | 555 |
|
|
2022
Q3 | $97.3M | Sell |
494,575
-5,484
| -1% | -$1.18M | 0.02% | 552 |
|
|
2022
Q2 | $107M | Sell |
500,059
-5,786
| -1% | -$1.41M | 0.02% | 545 |
|
|
2022
Q1 | $144M | Sell |
505,845
-11,644
| -2% | -$3.59M | 0.03% | 532 |
|
|
2021
Q4 | $195M | Sell |
517,489
-9,860
| -2% | -$3.83M | 0.03% | 458 |
|
|
2021
Q3 | $218M | Buy |
527,349
+14,387
| +3% | +$5.98M | 0.04% | 417 |
|
|
2021
Q2 | $190M | Buy |
512,962
+75,720
| +17% | +$25.3M | 0.03% | 461 |
|
|
2021
Q1 | $127M | Buy |
437,242
+40,500
| +10% | +$11.3M | 0.02% | 583 |
|
|
2020
Q4 | $99.1M | Sell |
396,742
-9,318
| -2% | -$2.22M | 0.02% | 644 |
|
|
2020
Q3 | $92M | Sell |
406,060
-18,041
| -4% | -$3.74M | 0.02% | 598 |
|
|
2020
Q2 | $73.9M | Buy |
424,101
+12,444
| +3% | +$1.99M | 0.02% | 649 |
|
|
2020
Q1 | $52M | Buy |
411,657
+18,226
| +5% | +$2.73M | 0.01% | 756 |
|
|
2019
Q4 | $60.1M | Buy |
393,431
+8,372
| +2% | +$1.16M | 0.01% | 885 |
|
|
2019
Q3 | $51M | Sell |
385,059
-1,937
| -0.5% | -$260K | 0.01% | 959 |
|
|
2019
Q2 | $54.9M | Buy |
386,996
+3,504
| +0.9% | +$475K | 0.01% | 923 |
|
|
2019
Q1 | $55.7M | Buy |
383,492
+10,570
| +3% | +$1.39M | 0.01% | 880 |
|
|
2018
Q4 | $42.2M | Buy |
372,922
+3,193
| +0.9% | +$400K | 0.01% | 990 |
|
|
2018
Q3 | $49.7M | Sell |
369,729
-10,669
| -3% | -$1.32M | 0.01% | 1032 |
|
|
2018
Q2 | $42.7M | Sell |
380,398
-31,649
| -8% | -$3.42M | 0.01% | 1148 |
|
|
2018
Q1 | $44M | Sell |
412,047
-11,600
| -3% | -$1.25M | 0.01% | 1083 |
|
|
2017
Q4 | $46.4M | Sell |
423,647
-2,652
| -0.6% | -$289K | 0.01% | 1028 |
|
|
2017
Q3 | $46M | Sell |
426,299
-10,561
| -2% | -$1.09M | 0.01% | 1023 |
|
|
2017
Q2 | $44.2M | Buy |
436,860
+6,304
| +1% | +$580K | 0.01% | 1019 |
|
|
2017
Q1 | $38.7M | Buy |
430,556
+10,133
| +2% | +$861K | 0.01% | 1120 |
|
|
2016
Q4 | $32M | Buy |
420,423
+251
| +0.1% | +$19.1K | 0.01% | 1231 |
|
|
2016
Q3 | $35M | Buy |
420,172
+9,496
| +2% | +$796K | 0.01% | 1114 |
|
|
2016
Q2 | $33.9M | Buy |
410,676
+3,597
| +0.9% | +$296K | 0.01% | 1083 |
|
|
2016
Q1 | $30.7M | Buy |
407,079
+13,574
| +3% | +$1M | 0.01% | 1147 |
|
|
2015
Q4 | $31.6M | Sell |
393,505
-3,922
| -1% | -$283K | 0.01% | 1132 |
|
|
2015
Q3 | $25.2M | Buy |
397,427
+6,339
| +2% | +$455K | 0.01% | 1322 |
|
|
2015
Q2 | $27.5M | Sell |
391,088
-8,152
| -2% | -$603K | 0.01% | 1317 |
|
|
2015
Q1 | $31.7M | Sell |
399,240
-4,288
| -1% | -$316K | 0.01% | 1219 |
|
|
2014
Q4 | $25.7M | Buy |
403,528
+20,846
| +5% | +$1.31M | 0.01% | 1343 |
|
|
2014
Q3 | $22.9M | Sell |
382,682
-22,336
| -6% | -$1.28M | 0.01% | 1396 |
|
|
2014
Q2 | $21.7M | Buy |
405,018
+9,550
| +2% | +$524K | 0.01% | 1454 |
|
|
2014
Q1 | $23.9M | Buy |
395,468
+1,939
| +0.5% | +$113K | 0.01% | 1432 |
|
|
2013
Q4 | $20.9M | Sell |
393,529
-3,656
| -0.9% | -$184K | 0.01% | 1489 |
|
|
2013
Q3 | $18.4M | Sell |
397,185
-11,860
| -3% | -$544K | 0.01% | 1520 |
|
|
2013
Q2 | $16.8M | Buy |
+409,045
| New | +$17.5M | 0.01% | 1515 |
|
Other funds holding CRL
VCM
VPM
Northern Trust's CRL Position: Q1 2026 in Review
Northern Trust increased its Charles River Laboratories (CRL) stake by 1.4% in Q1 2026, buying an estimated $1.15M and bringing the position to 445,382 shares worth $76.8M. The position accounts for 0.01% of the portfolio, ranked #867.
Northern Trust first reported a position in CRL in Q2 2013 and has held it in 52 quarters since. The position peaked at $218M in Q3 2021. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Northern Trust held 445,382 shares of Charles River Laboratories worth $76.8M as of Q1 2026.
- Northern Trust bought 6,221 Charles River Laboratories shares in Q1 2026, an estimated $1.15M.
- Charles River Laboratories made up 0.01% of Northern Trust's portfolio in Q1 2026, its #867 holding.
- Northern Trust first reported a position in Charles River Laboratories in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Charles River Laboratories position peaked at $218M in Q3 2021.
- 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.